What is the catalog number for KCNH2 Antibody - C-terminal region?

The catalog number for KCNH2 Antibody - C-terminal region is ARP35450_P050.

What sizes are available for KCNH2 Antibody - C-terminal region?

KCNH2 Antibody - C-terminal region is available in the following size(s): 100 µL.

Is KCNH2 Antibody - C-terminal region in stock?

KCNH2 Antibody - C-terminal region is currently made to order / not held in immediate stock. Contact us for lead time.

What buffer is this product supplied in?

The formulation or storage buffer is listed on the product datasheet. If you require a carrier-free or custom formulation, contact us before ordering, as this may involve a made-to-order production timeline.

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.

Can I request a Safety Data Sheet (SDS) for this product?

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

KCNH2 Antibody - C-terminal region

Product Specifications

CAS Number

9007-83-4

Gene Name

Potassium voltage-gated channel, subfamily H (eag-related), member 2

Gene Aliases

ERG1, HERG, LQT2, SQT1, ERG-1, H-ERG, HERG1, Kv11.1

Gene ID

3757

Swiss Prot

Q12809-2

Accession Number

NP_742054

Reactivity

Human, Mouse, Rat, Cow, Dog, Guinea Pig, Horse, Rabbit

Immunogen

The immunogen is a synthetic peptide directed towards the C-terminal region of human KCNH2

Target

This gene encodes a voltage-activated potassium channel belonging to the eag family. It shares sequence similarity with the Drosophila ether-a-go-go (eag) gene. Mutations in this gene can cause long QT syndrome type 2 (LQT2) .This gene encodes a voltage-activated potassium channel belonging to the eag family. It shares sequence similarity with the Drosophila ether-a-go-go (eag) gene. Mutations in this gene can cause long QT syndrome type 2 (LQT2) . Transcript variants encoding distinct isoforms have been identified.

Partner Proteins

UBC; NEDD4L; STUB1; HSP90AA1; RAB11A; FKBP8; STIP1; BAG2; HSPA8; DNAJA1; CANX; CALR; CUL1; CAV3; HSPA4; ALG10B; NDUFS6; ALG10; CDC73; YWHAE; KCNE2; RHOH; PRKACA; KCNE1; YWHAH

Clonality

Polyclonal

Type

Polyclonal Antibody

Sequence

SQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPG

Applications

Purification

Affinity Purified

Assay Protocol

Reconstitution & Storage Instructions Western Blotting/Immunoblotting (WB/IB) Protocol Immunohistochemistry (IHC) Protocol Immunocytochemistry (ICC) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Blocking Peptide Competition Protocol (BPCP) Immunoprecipitation (IP) Protocol Antibody Array (AA) Protocol Reconstitution & Storage Instructions Reconstitution & Storage Instructions Western Blotting/Immunoblotting (WB/IB) Protocol Western Blotting/Immunoblotting (WB/IB) Protocol Immunohistochemistry (IHC) Protocol Immunohistochemistry (IHC) Protocol Immunocytochemistry (ICC) Protocol Immunocytochemistry (ICC) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Blocking Peptide Competition Protocol (BPCP) Blocking Peptide Competition Protocol (BPCP) Immunoprecipitation (IP) Protocol Immunoprecipitation (IP) Protocol Antibody Array (AA) Protocol Antibody Array (AA) Protocol